Clinical Trial Update: A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

This entry describes an ongoing Phase 1/2 clinical trial evaluating VRT106 for injection in patients with recurrent or progressive glioblastoma, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• VRT106

Snippet

Sponsor: Guangzhou Virotech Pharmaceutical Co., Ltd. | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING